AbdurR.ShakirMD

PubMed

• Successful treatment of refractory secondary immune thrombocytopenia (antiphospholipid antibody syndrome-associated) with the combination of rituximab and romiplostim ...
  Gizem Yassa, Abdur R Shakir, Kuppuswamy Jagarlamudi, Ahmet Yassa
  Journal of Oncology Pharmacy Practice. 2021-01-01
• 3 citations
  Patients with NSCLCs Harboring Internal Inversions or Deletion Rearrangements of the ALK Gene Have Durable Responses to ALK Kinase Inhibitors
  Alexa B. Schrock, Russell Madison, Margaret Rosenzweig, Justin M. Allen, Rachel L. Erlich
  Lung Cancer. 2020-04-17
• 8 citations
  Hybrid Capture‐Based Comprehensive Genomic Profiling Identifies Lung Cancer Patients with Well‐Characterized Sensitizing Epidermal Growth Factor Receptor Point Mutatio...
  James Suh, Alexa B. Schrock, Adrienne Johnson, Doron Lipson, Shakti H. Ramkissoon
  The Oncologist. 2018-07-01

Journal Articles

• Patients with NSCLCs Harboring Internal Inversions or Deletion Rearrangements of the ALK Gene Have Durable Responses to ALK Kinase Inhibitors  
  Abdur Shakir, Lung Cancer: Targets and Therapy, 3/24/2020
• Rituximab plus concurrent radiation therapy for the management of CD20 -positive peripheral T- cell lymphoma: A case report and review of literature  
  Aranza Pinedo Pichilingue1* and Abdur R Shakir2,3, Cancer Reports and Reviews, 7/23/2018
• A Near-Complete Response to Treatment with Gemcitabine plus nab®-Paclitaxel in a Patient with Metastatic Pancreatic Cancer and Poor Performance Status: A Case Report  
  Shakir A.R., Case Rep Oncol 2014;7:711-717, 10/1/2014
• Strong and Sustained Response to Treatment with Carboplatin plus Nab-Paclitaxel in a Patient with Metastatic Triple-Negative BRCA1-Positive Breast Cancer  
  Shakir,AR, Case Rep Oncol 2014;7:252–259, 4/9/2014
• Join now to see all

Abstracts/Posters

• Hybrid-Capture Based Comprehensive Genomic Profiling Detects EGFR Point Mutations in >20% of Patients Missed by Standard of Care Testing
  James Suh, Alexa Schrock, Adrienne Johnson, Doron Lipson, Laurie Gay, Shakti Ramkissoon, Jo-Anne Vergilio, Julia Elvin, Abdur Shakir, Jeffrey Ross, Philip Stephens, Vi..., Journal of Thoracic Oncology, 1/2017
• Hematological adverse events of Temezolomide a review of FDA.
  Villano,L, Shakir,A, American Society of Clinical Oncology, Orlando, FL., 1/1/2009
• Thrombocytopenia (T) in patients with chronic hepatitis C: Management with interleukin 11.
  Charles L. Mendenhall, Abdur R. Shakir, Elizabeth A. Zoiss, Catrina Reese, Hai Bui, Stephen Goldberg and Gary A. Roselle, Gastroenterology; Digestive Disease Week and the 104th Annual Meeting of the American Gastroenterological Association, 4/1/2003
• Primary Hyperparathyroidism in 11 of 1265 (0.86%) patients referred for diagnosis and treatment of Hyperlipidemia.
  Goldenberg N, Shakir A, Glueck CJ, Journal of Investigative Medicine; National Clinical Research Meetings, Baltimore, MD., 3/14/2003
• Join now to see all

Lectures

• Being Well PBS-Lymphoma 
  https://www.youtube.com/watch?v=fQyjgoOOBiw - 9/23/2015
• Being Well PBS Lung Cancer 
  https://www.youtube.com/watch?v=5wZ_vLlh-Nk&feature=share&list=UUbflZcStX4cCeGlILq-3Klg&index=1 - 5/21/2014
• PBS-Being Well Prostate Cancer 
  https://www.youtube.com/watch?v=Jj-fo4xBeko - 10/12/2012
• Being Well PBS-Breast Cancer 
  https://www.youtube.com/watch?v=DMov22YIlv0&feature=share&list=PL3632DB13C870558B&index=47 - 5/21/2012
• Multiple Myeloma update in treatment. 
  Chicago, IL. - 1/1/2010
• Pseudo tumor progression vs. Tumor progression a diagnostic dilemma. 
  1/1/2009
• Molecular Therapy for Stage IV colon cancer. 
  Chicago, IL. - 1/1/2009
• Primary chemotherapy for Ependymoma. 
  1/1/2006
• Primary Brain Tumors, Understanding New Diagnostic Modalities. 
  1/1/2005
• Join now to see all